EMJ GOLD

Filter Advertise With Us

Scales and a tape measure on a blue background

Obesity care missing where demand is greatest, study shows

A global study into obesity rates around the world has revealed stark gaps.

Blue-gloved hand holding an orange capsule

OpenAI launches early drug discovery AI model

OpenAI has launched GPT-Rosalind, a domain-specific AI model aimed at improving efficiency in early-stage drug discovery.

Person's feet standing on scales with tape measure in front on the floor

Tirzepatide linked to more lean mass loss than semaglutide

The rivalry between Eli Lilly’s tirzepatide and Novo Nordisk’s semaglutide continues.

Exterior of glass AWS office building

Amazon launches AI platform for faster drug discovery

Amazon Web Services has launched a new AI platform to help drug developers identify and test potential candidates.

Novo partners with OpenAI to boost drug development

Novo Nordisk announced on 14 April 2026 a strategic partnership with OpenAI to boost drug development by streamlining manufacturing, supply chains and distribution.

Man talking to healthcare professional

£6.3m fund targets men’s health gap in England

A new fund has launched to tackle widening health inequalities among underserved men in England.

Biopharma company joins lawsuit over CMS hemp pilot

MMJ International Holdings has joined plaintiffs taking legal action against the CMS.

Novo Nordisk launches higher-dose semaglutide

Novo Nordisk has launched a 7.2 mg semaglutide injection in the US, following FDA approval on 19 March.

ASCVD costs global health industry $680bn annually

Atherosclerotic cardiovascular disease costs the equivalent of Sweden’s entire economy, a new report has revealed.

Loading posts...

« Previous 1 2 3 4 5 6 … 51 Next »